DK0699680T3 - Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse - Google Patents

Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse

Info

Publication number
DK0699680T3
DK0699680T3 DK95401989T DK95401989T DK0699680T3 DK 0699680 T3 DK0699680 T3 DK 0699680T3 DK 95401989 T DK95401989 T DK 95401989T DK 95401989 T DK95401989 T DK 95401989T DK 0699680 T3 DK0699680 T3 DK 0699680T3
Authority
DK
Denmark
Prior art keywords
oxazologuinolinone
derivatives
preparation
therapeutic use
ch2ome
Prior art date
Application number
DK95401989T
Other languages
Danish (da)
English (en)
Inventor
Samir Jegham
Jean Jacques Koenig
Philippe Burnier
Lydia Zard
Frederic Puech
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0699680T3 publication Critical patent/DK0699680T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Quinoline Compounds (AREA)
DK95401989T 1994-09-05 1995-09-01 Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse DK0699680T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9410600A FR2724171B1 (fr) 1994-09-05 1994-09-05 Derives de 3,3a,4,5-tetrahydro-1h-oxazolo(3,4-a)quinolein-1-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
DK0699680T3 true DK0699680T3 (da) 2000-08-21

Family

ID=9466686

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95401989T DK0699680T3 (da) 1994-09-05 1995-09-01 Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse

Country Status (28)

Country Link
US (1) US5641785A (no)
EP (1) EP0699680B1 (no)
JP (1) JP4225585B2 (no)
KR (1) KR100392523B1 (no)
CN (1) CN1055472C (no)
AT (1) ATE190311T1 (no)
AU (1) AU687591B2 (no)
CA (1) CA2157427C (no)
CZ (1) CZ286128B6 (no)
DE (1) DE69515402T2 (no)
DK (1) DK0699680T3 (no)
ES (1) ES2145886T3 (no)
FI (1) FI110945B (no)
FR (1) FR2724171B1 (no)
GR (1) GR3033554T3 (no)
HK (1) HK1013652A1 (no)
HU (1) HU218587B (no)
IL (1) IL115276A (no)
NO (1) NO306617B1 (no)
NZ (1) NZ272920A (no)
PL (1) PL184412B1 (no)
PT (1) PT699680E (no)
RU (1) RU2141482C1 (no)
SI (1) SI0699680T1 (no)
SK (1) SK281867B6 (no)
TW (1) TW356467B (no)
UA (1) UA41916C2 (no)
ZA (1) ZA957414B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
US7553967B2 (en) * 2004-03-12 2009-06-30 Wyeth 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections
AU2008226649B2 (en) * 2007-03-09 2013-08-01 Sanofi Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
RU2366430C2 (ru) 2007-05-23 2009-09-10 Виктор Иванович Рощин Ингибиторы моноаминооксидазы, лекарственное средство и фармацевтическая композиция
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
CN105949120B (zh) * 2016-05-27 2018-07-24 广东工业大学 一种四齿螯合型单喹啉衍生物及其制备方法和作为神经退行性疾病的金属离子调节剂的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
ES2013391A6 (es) * 1989-02-08 1990-05-01 Consejo Superior Investigacion Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles.
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法

Also Published As

Publication number Publication date
FI954141A (fi) 1996-03-06
NO953458L (no) 1996-03-06
NO953458D0 (no) 1995-09-04
DE69515402D1 (de) 2000-04-13
RU2141482C1 (ru) 1999-11-20
PL184412B1 (pl) 2002-10-31
UA41916C2 (uk) 2001-10-15
US5641785A (en) 1997-06-24
SK108995A3 (en) 1996-06-05
IL115276A (en) 1998-12-06
HU218587B (hu) 2000-10-28
EP0699680A1 (fr) 1996-03-06
DE69515402T2 (de) 2000-10-19
ATE190311T1 (de) 2000-03-15
SK281867B6 (sk) 2001-08-06
EP0699680B1 (fr) 2000-03-08
FR2724171A1 (fr) 1996-03-08
CZ286128B6 (cs) 2000-01-12
KR960010648A (ko) 1996-04-20
ES2145886T3 (es) 2000-07-16
FI954141A0 (fi) 1995-09-04
FR2724171B1 (fr) 1997-01-03
PL310273A1 (en) 1996-03-18
SI0699680T1 (en) 2000-10-31
IL115276A0 (en) 1996-01-19
AU3041595A (en) 1996-03-21
GR3033554T3 (en) 2000-09-29
CA2157427A1 (en) 1996-03-06
HU9502578D0 (en) 1995-11-28
AU687591B2 (en) 1998-02-26
HK1013652A1 (en) 1999-09-03
FI110945B (fi) 2003-04-30
TW356467B (en) 1999-04-21
NZ272920A (en) 1998-03-25
JP4225585B2 (ja) 2009-02-18
CN1128763A (zh) 1996-08-14
CN1055472C (zh) 2000-08-16
CA2157427C (en) 2010-06-01
CZ226295A3 (en) 1996-03-13
KR100392523B1 (ko) 2003-11-12
NO306617B1 (no) 1999-11-29
JPH0899881A (ja) 1996-04-16
ZA957414B (en) 1996-04-15
HUT73435A (en) 1996-07-29
PT699680E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
FI945703A (fi) 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus
FI925849A (fi) Tiazolidinfoereningar, deras framstaellning och terapeutiska anvaendningar
FI925848A0 (fi) Tizolidinfoereningar, som innehaoller en kinogrupp, deras framstaellning och terapeutiska anvaendningar
DK0699680T3 (da) Oxazologuinolinonderivater, deres fremstilling og deres terapeutiske anvendelse
ATE207887T1 (de) Neue n-aryl-2-hydroxy-alkylamide
DE69033342T2 (de) Etoposidanaloge
NO964269D0 (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
ATE124686T1 (de) Phenylalkylamine und diese enthaltende fungizide.
FR2716198B1 (fr) Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
FI912269A0 (fi) 3'-deamino - 4'deoxi - 4'-amino- 8 -fluorantracykliner och framstaellningsfoerfaranden foer dessa.
FR2682378B1 (fr) Nouveaux derives de l'acide fluoroquinoleine carboxylique-3 et leur preparation.
DE3865521D1 (de) 4-methyl-4-phenyl-1-pentanale, deren herstellung und verwendung als riechstoffe.
ATE12645T1 (de) Phenylethylthiazolderivate, ihre herstellung und ihre anwendung in der therapeutik.
SU1690242A1 (ru) Антифидант
SU1427799A1 (ru) ПРОИЗВОДНЫЕ 9,11-(β,β-ДИМЕТИЛТРИМЕТИЛЕН)-ТИАХИНО-4'-ТЕТРАКАРБОЦИАНИНОВ В КАЧЕСТВЕ СПЕКТРАЛЬНЫХ СЕНСИБИЛИЗАТОРОВ БРОМЙОДСЕРЕБРЯНЫХ ФОТОГРАФИЧЕСКИХ ЭМУЛЬСИЙ